AVP and coronary artery disorder: Fenske et al. have reported an increased incidence of CV events in a subgroup of ESRD patients who had elevated levels of copeptin (73), and Engelbertz et al. showed elevated copeptin as a prognostic factor, independent of serum creatinine (SCr) in patients with both CAD and CKD (74).